Replies to post #126836 on Biotech Values

[turtlepower]

I meant to ask a question about the effect on copaxone growth "if" multiple generics are approved. Annualized copaxone sales are about 2.7 B now. Annual growth could slow or perhaps even drop if multiple copaxone generics are approved and was wondering what was more likely.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65594032